The present invention provides a novel pyrazolo[3,4-d]pyrimidin-4-one, specifically a derivative of 1-(pyridine-4-yl)-pyrazolo[3,4-d]pyrimidin-4-one. This compound is a kinase inhibitor that shows unexpected anti-proliferative activity against cells, including against tumor cells, and anti-tumor activity in xenograft tumor models. The compound or a suitable salt or prodrug thereof is useful for the treatment of individuals suffering from a cancer or another proliferative disorder or disease.
Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor
申请人:GPC Biotech AG
公开号:EP2019101A1
公开(公告)日:2009-01-28
The present invention provides a novel pyrazolo[3,4-d]pyrimidin-4-one of formula (I), specifically a derivative of 1-(pyridin-4-yl)-pyrazolo[3,4-d]pyrimidin-4-one. This compound is a kinase inhibitor that shows unexpected anti-proliferative activity against cells, including against tumor cells, and anti-tumor activity in xenograft tumor models. The compound or a suitable salt or prodrug thereof is useful for the treatment of individuals suffering from a cancer or another proliferative disorder or disease.
[EN] PYRAZOLOPYRIMIDINONE KINASE INHIBITOR<br/>[FR] INHIBITEUR DE PYRAZOLOPYRIMIDINONE KINASES
申请人:GPC BIOTECH AG
公开号:WO2008145678A1
公开(公告)日:2008-12-04
[EN] The present invention provides a novel pyrazolo[3,4-d]pyrimidin-4-one, specifically a derivative of 1-(pyridin-4-yl)-pyrazolo[3,4-d]pyrimidin-4-one. This compound is a kinase inhibitor that shows unexpected anti-proliferative activity against cells, including against tumor cells, and anti-tumor activity in xenograft tumor models. The compound or a suitable salt or prodrug thereof is useful for the treatment of individuals suffering from a cancer or another proliferative disorder or disease. [FR] L'invention concerne un nouveau composé de pyrazolo[3,4-d]pyrimidin-4-one, spécifiquement un dérivé de 1-(pyridin-4-yl)-pyrazolo[3,4-d]pyrimidin-4-one. Ce composé constitue un inhibiteur de kinases qui présente une activité antiproliférante inattendue contre certaines cellules, y compris des cellules tumorales, et une activité antitumorale dans des modèles de tumeur de xénogreffe. Ce composé, ou un sel ou un promédicament approprié de celui-ci, est utile pour traiter des sujets atteints d'un cancer ou d'un autre trouble proliférant ou d'une autre maladie proliférante.